Quickyla Pulse
Choose Language
Select a language for news translation.
Results for "ticker:ABBV"
3 articles
📈 Markets & Finance
AbbVie's Migraine Franchise Scored a Big Win. Is This Dividend King a No-Brainer Buy Right Now?
Written by Prosper Junior Bakiny for The Motley Fool Key Points AbbVie's Qulipta could be racing toward another label expansion, given a recent clinical trial…
📈 Markets & Finance
Why Did Billionaire Israel "Izzy" Englander More Than Double His Stake in AbbVie Stock and Start a Position in SpaceX Stock?
Written by Selena Maranjian for The Motley Fool Key Points AbbVie is a diversified pharmaceutical company. Its dividend yields 2.7% -- and that payout has bee…
📈 Markets & Finance
Is AbbVie (ABBV)’s $10.9 Billion Apogee Therapeutics (APGE) Deal the Next Catalyst for Growth?
On September 3, AbbVie Inc. (NYSE: ABBV ) finalized its acquisition of clinical-stage biotech Apogee Therapeutics, Inc. (NASDAQ: APGE ) for $135.11 per share i…
Markets
Full Markets →
Local Weather
—°F
Local area
58% 12 mphH:78° L:61°
Emergency Alerts
{# These used to be hardcoded, permanently-displayed example alerts
("Wildfire Warning... until 8PM") with no real data source — that's
fabricated safety information shown to every visitor regardless of
actual conditions. Removed rather than left live; a real version
needs a genuine feed (e.g. the free NWS alerts API) behind it. #}
No active alerts for your area right now.
AI Powered
Summarize any article instantly
Get 30-second summaries, bullet points, deep analysis, or a child-friendly version — powered by AI.
30-sec summary
Bullet points
Deep analysis
Based on Your Interests
Trending stories you might like
Around the World
Video News
